CLINICAL_TRIALS
trial_result
· 2022-09-28
Clinical Trial Update: Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery [Phase 2]
Summary
Phase 2 trial evaluating riluzole for unresectable stage III/IV melanoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rutgers, The State University of New Jersey | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED | Results posted: 2022-09-28